DTAB Recommends To Form Sub-Committee To Examine Requirement Of RMP For Sales Of Cough Syrups

New Delhi : The Drugs Technical Advisory Board (DTAB) has recommended formation of a sub-committee to examine aspects including the requirement of Registered Medical Practitioner (RMP) for sale of various cough syrups in the country.

A recent meeting of the DTAB made the recommendation while looking into a representation received from Mumbai-based USV Pvt Ltd to move its approved drug Dried Ivy Leaf Extract Cough Syrup, from prescription drug to the Schedule K of the Drugs and Cosmetics Rules, 1945.

USV has requested for marketing of approved drug “Dried Ivy Leaf Extract Cough Syrup” under Schedule K (Rule 123) and requested exemption from the “WARNING: “To be sold by retail on the prescription of a RMP only”

It has also submitted the proposal and a recommendation from the Subject Expert Committee for the consideration of the Board.

“DTAB deliberated the matter and recommended that a sub-committee should be constituted to examine the proposal and also to examine the requirement of RMP for sale of various cough syrups in the country,” concluded the Board.

The SEC, which advises the drug regulator on matters related to Pulmonary therapeutic segment, in its 60th meeting on June 7, 2022, recommended for exemption of the drug from ‘Warning’ label requirement for marketing of the cough syrup. It also opined that an opinion from a phytopharmaceutical expert may be obtained for further proceedings.

Prior to the recommendation, the company presented patient safety data, details of concentration of Saponin in the reduction and the details of countries in which the product is marketed, package insert and regulatory status before the committee.

USV sells Prospan brand of dried ivy leaf extract based cough syrup in the market. The company, in its website claims that the exclusive extract from the leaves is carefully made using a patented extraction process and backed by years of clinical research.

It may be noted that the decision to look into the requirement of RMP for the same of various cough syrups in the country comes at a time when there has been an increased focus on the quality of cough syrups manufactured and exported from the country.

Related Posts

  • Pharma
  • July 24, 2025
  • 185 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 270 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra